Five details:
1. Teladoc posted a $333.5 million net loss for the first half of 2021, up from a net loss of $53.3 million during the first six months of 2020.
2. Teladoc attributed the greater net loss to expenses associated with stock awards from its Livongo merger; the companies finalized their merger last October for $18.5 billion.
3. Teladoc’s second-quarter revenue grew to $503 million, up 109 percent from $241 million during the same period in 2020.
4. The telehealth company reported 3.5 million visits during the second quarter, up 28 percent from the second quarter of 2020.
5. For the third quarter, Teladoc expects revenue to be in the range of $510 million to $520 million, with total visits clocking in between 3.4 million and 3.6 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
